These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12465750)

  • 1. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoprevention of prostate cancer].
    Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
    Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer chemoprevention.
    Sandhu GS; Nepple KG; Tanagho YS; Andriole GL
    Semin Oncol; 2013 Jun; 40(3):276-85. PubMed ID: 23806493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic prevention studies of prostate cancer.
    Djavan B; Zlotta A; Schulman C; Teillac P; Iversen P; Boccon Gibod L; Bartsch G; Marberger M
    J Urol; 2004 Feb; 171(2 Pt 2):S10-3; discussion S13-4. PubMed ID: 14713746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
    Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of prostate cancer: current status and future directions.
    Lieberman R
    Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of prostate cancer prevention.
    Brawley OW; Barnes S; Parnes H
    Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent approaches in chemoprevention of prostate cancer.
    Young CY
    Curr Cancer Drug Targets; 2007 Nov; 7(7):681-8. PubMed ID: 18045073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
    Parnes HL; House MG; Kagan J; Kausal DJ; Lieberman R
    J Urol; 2004 Feb; 171(2 Pt 2):S68-74; discussion S75. PubMed ID: 14713758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
    Lieberman R
    Urology; 2001 Aug; 58(2 Suppl 1):83-90. PubMed ID: 11502457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Future for Chemoprevention of Prostate Cancer?
    Bosland MC
    Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
    McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE
    Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New opportunities in chemoprevention research.
    Kucuk O
    Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.